Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TransCon IL-2 beta/gamma |
Trade Name | |
Synonyms | TransCon IL-2b/g |
Drug Descriptions |
TransCon IL-2 beta/gamma is a hydrogel based formulation of an IL-2 variant, which may lead to activation of cytotoxic T-lymphocytes and NK cells, and increased antitumor immune response, potentially resulting in tumor cell death (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C185290 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + TransCon IL-2 beta/gamma | Pembrolizumab TransCon IL-2 beta/gamma | 0 | 1 |
TransCon IL-2 beta/gamma | TransCon IL-2 beta/gamma | 0 | 1 |
TransCon IL-2 beta/gamma + TransCon TLR7/8 Agonist | TransCon IL-2 beta/gamma TransCon TLR7/8 Agonist | 0 | 1 |